Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

Sarah L. George; Mimi A. Wong; Tina J. T. Dube; Karen L. Boroughs; Janae L. Stovall; Betty E. Luy; Aurelia A. Haller; Jorge E. Osorio; Linda M. Eggemeyer; Sharon Irby-Moore; Sharon E. Frey; Claire Y.-H. Huang; Dan T. Stinchcomb

doi:10.1093/infdis/jiv179

Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial

The Journal of Infectious Diseases ◽

10.1093/infdis/jiv179 ◽

2015 ◽

Vol 212 (7) ◽

pp. 1032-1041 ◽

Cited By ~ 48

Author(s):

Sarah L. George ◽

Mimi A. Wong ◽

Tina J. T. Dube ◽

Karen L. Boroughs ◽

Janae L. Stovall ◽

...

Keyword(s):

Clinical Trial ◽

Vaccine Candidate ◽

Phase 1 ◽

Dengue Vaccine ◽

Phase 1 Clinical Trial ◽

Double Blinded

Download Full-text

Safety and efficacy of Lomecel‐B in patients with mild Alzheimer’s disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial

Alzheimer s & Dementia ◽

10.1002/alz.057581 ◽

2021 ◽

Vol 17 (S9) ◽

Author(s):

Anthony A. Oliva ◽

Mark Brody ◽

Marc Agronin ◽

Brad Herskowitz ◽

Susan Y Bookheimer ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Clinical Trial ◽

Phase 1 ◽

Safety And Efficacy ◽

Phase 1 Clinical Trial ◽

Double Blinded

Download Full-text

Faculty Opinions recommendation of Effectiveness of head-mounted vibrotactile stimulation in subjects with bilateral vestibular loss: a phase 1 clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1164123.624796 ◽

2009 ◽

Author(s):

Joseph Furman ◽

Maha Tayseer Mohammad

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Vibrotactile Stimulation ◽

Vestibular Loss ◽

Phase 1 Clinical Trial ◽

Bilateral Vestibular Loss

Download Full-text

Faculty Opinions recommendation of Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726267557.793519993 ◽

2016 ◽

Author(s):

John Laffey

Keyword(s):

Clinical Trial ◽

Stromal Cells ◽

Phase 1 ◽

Phase 1 Clinical Trial

Download Full-text

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial

Vaccine ◽

10.1016/j.vaccine.2021.05.070 ◽

2021 ◽

Author(s):

Yanxia Wang ◽

Yuhui Zhang ◽

Haofei Wu ◽

Lili Huang ◽

Hailong Yu ◽

...

Keyword(s):

Clinical Trial ◽

Influenza Vaccine ◽

Phase 1 ◽

Double Blind ◽

Phase 1 Clinical Trial

Download Full-text

A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome

Vaccine ◽

10.1016/j.vaccine.2012.01.024 ◽

2012 ◽

Vol 30 (11) ◽

pp. 1951-1958 ◽

Cited By ~ 43

Author(s):

Ellen F. Boudreau ◽

Matthew Josleyn ◽

Diane Ullman ◽

Diana Fisher ◽

Lonnie Dalrymple ◽

...

Keyword(s):

Clinical Trial ◽

Dna Vaccines ◽

Phase 1 ◽

Hemorrhagic Fever ◽

Hantaan Virus ◽

Puumala Virus ◽

Phase 1 Clinical Trial

Download Full-text

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

The Journal of Infectious Diseases ◽

10.1093/infdis/jis497 ◽

2012 ◽

Vol 206 (8) ◽

pp. 1280-1290 ◽

Cited By ~ 100

Author(s):

Isabel Leroux-Roels ◽

Geert Leroux-Roels ◽

Frédéric Clement ◽

Pierre Vandepapelière ◽

Ventzislav Vassilev ◽

...

Keyword(s):

Older Adults ◽

Clinical Trial ◽

Subunit Vaccine ◽

Vaccine Candidate ◽

Phase 1 ◽

Glycoprotein E ◽

Varicella Zoster

Download Full-text

1238 POSTER Phase 1 Clinical Trial of Oral PPAR – Agonist Efatutazone (CS-7017) in Japanese Patients With Metastatic Solid Tumours

European Journal of Cancer ◽

10.1016/s0959-8049(11)70850-4 ◽

2011 ◽

Vol 47 ◽

pp. S156

Author(s):

N. Yamamoto ◽

H. Murakami ◽

Y. Onozawa ◽

T. Ono ◽

T. Tushima ◽

...

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Japanese Patients ◽

Solid Tumours ◽

Phase 1 Clinical Trial ◽

Ppar Agonist

Download Full-text

Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants

The Lancet Oncology ◽

10.1016/s1470-2045(21)00377-6 ◽

2021 ◽

Author(s):

Morgan A Casal ◽

S Percy Ivy ◽

Jan H Beumer ◽

Thomas D Nolin

Keyword(s):

Clinical Trial ◽

Glomerular Filtration Rate ◽

Glomerular Filtration ◽

Retrospective Analysis ◽

National Cancer Institute ◽

Filtration Rate ◽

Phase 1 ◽

Drug Dosing ◽

Phase 1 Clinical Trial ◽

Trial Participants

Download Full-text

Abstract TMIM-073: THE COMBINATION OF INTERFERONS ALPHA AND GAMMA AND MONOCYTES INDUCES OVARIAN CANCER CELL DEATH AND PROVIDE A RATIONALE FOR A NOVEL, ONGOING, IMMUNOTHERAPY PHASE 1 CLINICAL TRIAL

10.1158/1557-3265.ovcasymp18-tmim-073 ◽

2019 ◽

Author(s):

Daniel S. Green ◽

Chase L. Johnson ◽

Chen-Feng Qi ◽

Kevin W. Tosh ◽

Olena Kamenyeva ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Cell Death ◽

Cancer Cell ◽

Ovarian Cancer Cell ◽

Phase 1 ◽

Phase 1 Clinical Trial ◽

Cancer Cell Death

Download Full-text

A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor

Blood ◽

10.1182/blood-2013-09-527226 ◽

2014 ◽

Vol 123 (15) ◽

pp. 2308-2316 ◽

Cited By ~ 90

Author(s):

David H. McDermott ◽

Qian Liu ◽

Daniel Velez ◽

Lizbeeth Lopez ◽

Sandra Anaya-O’Brien ◽

...

Keyword(s):

Clinical Trial ◽

Low Dose ◽

Phase 1 ◽

Cxcr4 Antagonist ◽

Phase 1 Clinical Trial ◽

Dose Treatment ◽

Whim Syndrome ◽

Key Points

Key Points Plerixafor can be given safely to WHIM syndrome patients twice daily for a 6-month period and appears promising as a treatment.

Download Full-text